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The CRISPR system provides adaptive immunity against mobile genetic elements in pro-
karyotes. On binding invading RNA species, Type III CRISPR systems generate cyclic oli-
goadenylate (cOA) signalling molecules, potentiating a powerful immune response by
activating downstream effector proteins, leading to viral clearance, cell dormancy or death.
Here we describe the structure and mechanism of a cOA-activated CRISPR defence DNA
endonuclease, CRISPR ancillary nuclease 1 (Can1). Can1 has a unique monomeric structure
with two CRISPR associated Rossman fold (CARF) domains and two DNA nuclease-like
domains. The crystal structure of the enzyme has been captured in the activated state, with a
cyclic tetra-adenylate (cA4) molecule bound at the core of the protein. cA4 binding reor-
ganises the structure to license a metal-dependent DNA nuclease activity specific for nicking
of supercoiled DNA. DNA nicking by Can1 is predicted to slow down viral replication kinetics
by leading to the collapse of DNA replication forks.
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Type III (Csm/Cmr) CRISPR systems utilise a cyclasedomain in the Cas10 subunit to generate cyclic oligoade-nylate (cOA) by polymerising ATP1–3. The cyclase activity
is activated by target RNA binding and switched off by sub-
sequent RNA cleavage and dissociation1,4. cOA is a potent anti-
viral second messenger that sculpts the anti-viral response by
binding to and activating CRISPR associated Rossman fold
(CARF) family proteins5. The only CARF family effectors to be
characterised to date are dimeric ribonucleases of the Csx1/Csm6
family, which have a C-terminal HEPN (Higher Eukaryotes and
Prokaryotes, Nucleotide binding) domain that is allosterically
activated by cOA binding in the CARF domain6–9. Csm6 from
Enterococcus italicus and Streptococcus thermophilus are activated
by cyclic hexa-adenylate (cA6)2,3, while Csx1 from Sulfolobus
solfataricus and Csm6 from Thermus thermophilus are activated
by the cyclic tetra-adenylate (cA4) molecule1,2,10. In addition
to ribonucleases, a wide range of CARF family proteins have
been identified, including transcription factors such as Csa311,
cA4-degrading ring nucleases12 and putative membrane proteins
of unknown function5,13, suggesting that much remains to
be discovered. The cOA signalling pathway is crucial for defence
against mobile genetic elements (viruses and plasmids) in mul-
tiple different systems7,14–17. In infected cells, activation of Csm6
results in degradation of both host and invading RNA, leading to
significant reductions in cell growth until infection is cleared17.
T. thermophilus has well characterised type III CRISPR systems
and accessory proteins. The T. thermophilus Cmr (type III-B)
complex was one of the first studied biochemically, revealing the
distinctive cleavage of target RNA with 6 nucleotide spacing18,19.
High resolution cryo-EM studies revealed the mechanistic basis of
this RNA cleavage by the backbone subunit Cmr420. The T.
thermophilus Csm (Type III-A) complex was shown to possess
both sequence specific RNA cleavage and RNA-dependent
DNA degradation activities, fitting the emerging consensus
for type III CRISPR defence21. The crystal structure of the
T. thermophilus Csm6 (TTHB152) protein revealed a dimeric
arrangement with a HEPN nuclease domain possessing weak
ribonuclease activity and a CARF domain postulated to bind
activating ligands6. This was subsequently confirmed with the
discovery that the cyclase domain of Cas10 generates cyclic oli-
goadenylates that activate CARF domain proteins, including
Csm6, which is stimulated by cA4 binding to become a much
more active ribonuclease2. A second Csm6 orthologue
(TTHB144) was recently shown to be activated by cA4 binding
and also capable of cA4 degradation—the first example of a self-
limiting Csm6-family protein10.
TTHB155, hereafter Can1 (CRISPR ancillary nuclease 1), was
identified as a potential accessory protein of the type III CRISPR
system by Shah et al. in 2018 (cluster 107)22. The gene is strongly
up-regulated following phage infection in T. thermophilus and is
situated adjacent to the CRISPR-5 locus, with operons encoding
subunits of the Cmr and Csm complexes nearby23. Can1 is a large
protein, 636 amino acids in length. Sequence analysis using
HHPRED24 suggested the presence of two CARF domains, one at
the N-terminus and one towards the centre of the protein,
together with a C-terminal PD-D/ExK family metal-dependent
nuclease domain (Fig. 1a). The protein therefore has a number of
unique features that have not been investigated previously. Here,
we show that Can1 is a metal dependent DNA nuclease, activated
by cA4 binding. The structure of Can1 bound to cA4 reveals
extensive structural reorganisation around the activator, bringing
the two nuclease-like domains together and forming a DNA
binding interface with an active site for DNA cleavage. The
enzyme preferentially nicks supercoiled DNA to generate liga-
table products, which may slow down viral replication without
causing catastrophic damage to the host genome.
Results
Overall structure of Can1 bound to cA4. A synthetic gene
encoding Can1 was constructed and cloned into the E. coli
expression vector pEV5HisTEV25. The protein was expressed
with an N-terminal, TEV protease-cleavable polyhistidine tag,
and purified by immobilised metal affinity chromatography and
gel filtration, with concomitant tag removal, as described in the
Methods. Given the observation that the T. thermophilus Csm6
ribonucleases are activated by cA42,10, we reasoned that Can1
might bind the same activator. Can1, with selenomethionine
incorporated, was crystallised in the presence of cA4. Diffraction
data were collected at Diamond Light Source to 1.83 Å resolution
and phased using the incorporated selenium atoms. Following
autobuilding of the model, it was refined to a final Rwork of 18%
and Rfree of 21%. The protein chain is traced from residue 3 to
638, with three short sections too disordered to model (464-471,
491-494 and 530-539). Efforts were made to crystallise apo Can1,
but no crystals were forthcoming.
The structure of Can1 is unique, with four distinct domains
linked by flexible loops (Fig. 1). At the N-terminus there is a
CARF domain (residues 3-151), domain 2 (residues 168-276), a
second CARF domain (residues 293-422) and a nuclease domain
(residues 426-638). The two CARF domains display a canonical
Rossman fold, with the addition of a β-strand compared to other
reported CARF domain structures; each domain comprises a core
of five parallel β-strands alternating with four α-helices
(Supplementary Fig. 1). This is followed by a further two
β-strands that form a beta-hairpin, and an α-helix. The nuclease
domain at the C-terminus comprises a central core of six
β-strands flanked by six α-helices typical of the PD-D/ExK metal-
dependent nuclease family26. Domain 2 comprises five β-strands
flanked by four α-helices, reminiscent of part of the core domain
of the PD-D/ExK nuclease family, with a helix-turn-helix motif
between the second and third helices.
cA4 recognition by Can1. There is unambiguous electron density
in the Fobs—Fcalc map at 3σ corresponding to a molecule of cA4
bound to Can1 (Fig. 2a), which was modelled following genera-
tion of the library in Acedrg27. The molecule of cA4 sits at the
interface between the two CARF domains of Can1 and is com-
pletely enclosed by the protein (Fig. 1c). There are a fairly modest
number of hydrogen bond interactions between Can1 and cA4
given its size, all but one of which originate from the two CARF
domains (Fig. 2b and Supplementary Fig. 2). For clarity, the AMP
moieties in cA4 have been arbitrarily named A1-4. There are
hydrogen bonds formed between three of the AMP moieties in
cA4 (A1, A2 and A3) and residues in the first CARF domain;
these interactions are formed via main chain atoms of residues
Lys90, Asn12, Asp13 and Gly88, and side chain atoms of residues
Lys90, Asn12, Tyr143, His113 and Tyr147. Likewise, there are
hydrogen bond interactions formed between three of the AMP
moieties in cA4 (A1, A3 and A4) and residues in the second
CARF domain; these are formed via main chain atoms of residues
Thr384, Gln301, Gly405 and Asn380, and side chain atoms of
residues Tyr402, Thr384, Glu324, Thr322, Ser299 and Asn380. A
total of 19 water molecules also hydrogen bond directly with cA4.
Superposition of the four adenosine units (centred on the
carbon atoms in the ribose sugar) within cA4 show a marked
difference in the conformation of one of them (Supplementary
Fig. 3). Whilst three of the adenosine moieties superimpose well
(with respect to the ribose sugar and imidazole moiety of the
adenine base; one adenine base is flipped compared to the other
two but in the same plane), the adenine of the other adenosine
moiety (A1) is in a more axial position at the anomeric carbon.
This adenine base displays a clear π-π stacking interaction with
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Trp42, which appears to be the driving force for this alternate,
and most probably higher energy, conformation for the adenine.
It has the knock-on effect of causing the ribose sugar to display a
2’-exo conformation, compared to an 2’-endo conformation
which is observed in the other adenosine units.
Only two residues from the nuclease domain and domain 2 are
in close proximity to cA4. Gly550, from the nuclease domain,
forms a hydrogen bond interaction via its main chain carboxyl
group to the adenine moiety of A4 (Fig. 2b). Gln222 from domain
2 does not interact directly with any atoms in cA4, but hovers
above the centre of the cA4 molecule, and makes two water-
mediated interactions to opposite phosphate groups in cA4
(Supplementary Fig. 4). To investigate the importance of these
interactions for ligand binding, we engineered and purified the
CARF domain variants N12A, W42A, K90E, H113A and Q222E.
The effects of these changes on cA4 binding were monitored by
electrophoretic mobility shift assay (EMSA) using labelled cA4.
Binding of cA4 was abolished for the K90E variant, severely
reduced for the N12A variant, and moderately affected for W42A,
H113A and Q222E (Supplementary Fig. 5). These observations
highlight the distributed nature of cA4 interactions and the
crucial role of Lys90, which is situated at the base of the cA4
binding pocket.
All other characterised CARF family proteins consist of a single
CARF domain, which homo-dimerises to bind one molecule of
cOA. Can1 is unique as it possesses two CARF domains in a
single polypeptide. The CARF domains superimpose with an
RMSD of 2.5 Å over 113 Cα atoms, although few residues are
conserved (Supplementary Figs. 6 and 7A). A striking feature of
cA4 recognition is the asymmetry of the interactions formed with
Can1, as the interactions with each AMP moiety are distinct. The
comparison highlights the structural equivalence of Asp13 and
Gln301, which both make main chain interactions with cA4 (A1
and A3, respectively), and of Lys90 and Thr384 (A2 and A4,
respectively), which both make main chain and side chain
interactions with cA4.
Structural comparisons of the cA4 binding site. DALI28 sear-
ches for the nearest structural homologue to each CARF domain
in Can1 gave identical results for each: hypothetical protein
VC1899 (PDB: 1XMX), a CARF family protein that is a member
of the DUF1887 family. The CARF dimer (taken as the two
domains from a single polypeptide chain) of Can1 superimposes
with the CARF dimer (formed by two monomers) of VC1899
with an RMSD of 3.6 Å over 294 Cα atoms (Fig. 3a). This
superimposition allows exploration of likely interactions between
VC1899 and cA4. All of the main chain interactions observed
between Can1 and cA4 are likely conserved, as are a number of
the side chain interactions (Supplementary Figs. 6 and 7B). There
is no equivalent in VC1899 to Trp42, the residue responsible for
causing one of the adenine bases (from A1) to sit in a more axial
conformation with respect to the ribose sugar. With the absence
of this interaction this adenine may not be in such a strained
position when bound to VC1899, and there is sufficient room in
the binding site for this to fit in a more relaxed position (Fig. 3b).
Few close interactions/clashes between cA4 and VC1899 are
predicted, and these involve side chains which could easily be
repositioned, suggesting there is little rearrangement of either the
CARF dimer or of residues in the CARF domains upon binding
of cA4. In other words, with the caveat that VC1899 has not yet
been demonstrated to bind cA4, the cA4 binding site of Can1 is
likely to be largely pre-formed in the apo-protein.
The nuclease and nuclease-like domains. DALI searches for
structural homologues of the nuclease domain of Can1 once again
gave the hypothetical protein VC1899 (PBD: 1XMX) as the
highest hit. The nuclease domain from Can1 superimposes with
the nuclease domain of VC1899 with an RMSD of 3.4 Å over 160
Cα atoms (Fig. 3c, with nuclease active site residues shown).
Whilst the core of the nuclease domain is very similar, Can1 has
an extra helix-loop-helix feature between residues 441 and 498,
whereas at the equivalent position (residues 156-248) VC1899
possesses a non-superimposable section. The active site residues
Glu541, Asp543, Glu560 and Lys562 in Can1 overlap with
equivalent active site residues in VC1899. The closest structural
homologues with dsDNA bound are the type 2 restriction
enzymes AgeI (PDB: 5DWB29) and NgoMIV (PDB: 1FIU30),
which overlap with the nuclease domain of Can1 with an RMSD
of 4.0 Å over 143 Cα atoms and 3.4 Å over 133 Cα atoms,
respectively (Supplementary Fig. 8). The core secondary structure
elements of the nuclease domain of Can1 and each of
the restriction enzymes are conserved, and the active site residue
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Fig. 1 Domain organisation and structure of Can1. a Domain organisation of Can1 with residue numbers indicated. Residues Glu541 and Asp543 are in the
nuclease active site. b Two views of the overall structure of Can1 shown in cartoon representation. Coloured as in panel (a): first CARF domain (magenta),
domain 2/nuclease-like domain (cyan), second CARF domain (green), nuclease domain (orange), loops between domains (grey). A molecule of cA4 bound
to Can1 is shown in sphere representation (carbon in yellow, nitrogen in blue, oxygen in red). c Overall structure of Can1, as coloured in panel (b), with
surface representation to illustrate cA4 is completely buried.
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Fig. 2 Structure of the cA4 activator and interactions with Can1. a Divergent stereo representation of cA4 (in stick representation; carbon in yellow,
nitrogen in blue, oxygen in red) with the maximum likelihood/σA weighted Fobs—Fcalc electron density map contoured at 3.0 sigma shown in red.
b Divergent stereo representation of the binding site of cA4 in complex with Can1. cA4 (with each AMP numbered A1-A4) and binding site residues are
shown in stick representation, with cA4 in yellow and amino acid residues coloured by the domain from which they originate (CARF domain 1: magenta,
domain 2/nuclease-like domain: cyan, CARF domain 2: green, nuclease domain: orange). The dotted lines represent hydrogen bond interactions.
a b c
Fig. 3 Structural comparison of Can1 and the DUF1887 family protein VC1899. a Superimposition of the CARF domains from Can1 (coloured as in Fig. 1)
in complex with cA4 (yellow spheres) with the CARF domain from VC1899 (mauve). The VC1899 dimer (monomer plus the symmetry mate that forms the
functional dimer) was overlapped with Can1. b Surface and cartoon representation of VC1899, with cA4 (yellow spheres) modelled based on the
superimposition shown in panel (a). c Superimposition of the nuclease domain from Can1 (orange) and the nuclease domain from VC1899 (mauve). The
active site residues are shown as sticks.
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Asp543 in Can1 overlaps with Asp142 in the AgeI nuclease and
Asp140 in the NgoMIV nuclease. Thus, the approximate binding
position of the dsDNA in complex with Can1 can be predicted
with some confidence (Fig. 4a).
Perhaps more surprisingly, DALI searches revealed that the top
hit for homologues of domain 2 of Can1 is also VC1899, which
overlaps with an RMSD of 2.5 Å over 86 Cα atoms. Domain 2 of
Can1 also superimposes with the nuclease domain of Can1 with
an RMSD of 2.6 Å over Cα 83 atoms, but it lacks the canonical
nuclease active site residues of either (Supplementary Fig. 9). We
herewith refer to domain 2 as the “nuclease-like domain”.
Can1 is a cA4 activated, metal dependent DNA nuclease. The
variants E541A/D543A, targeting the PD-D/ExK active site,
K90E, targeting a key interaction with cA4 in the CARF domain,
and R206E/R249E, targeting a putative DNA binding site in the
nuclease-like domain, were expressed and purified as for the wild-
type enzyme. Wild-type Can1 (200 nM) cleaved a supercoiled
plasmid substrate (2 nM) in the presence of 200 nM cA4 and
5 mM MnCl2 (Fig. 4b). The majority of the plasmid was nicked
within 1 min, with a small amount linearised after 5 min incu-
bation. Reactions in the absence of MnCl2 or cA4 showed very
little activity, confirming that Can1 is a metal dependent DNA
nuclease activated by cA4. Moreover, variants E541A/D543A
(nuclease variant) and K90E (CARF domain variant) were both
catalytically inactive, as expected for a cA4-activated PD-D/ExK
family nuclease. The R206E/R249E variant, which reverses two
positive charges on the surface of the nuclease-like domain, was
also inactive, suggesting a role for this domain in DNA binding.
These residues are in reasonably close proximity to the predicted
position of the dsDNA (Fig. 4a), and the nuclease-like domain
may move closer still upon DNA binding. Moderate reductions in
cA4 cleavage were observed for the other cA4-interacting residue
variants tested (Supplementary Fig. 5B).
On extended incubation over 2 h, Can1 slowly degraded the
nicked plasmid to linear fragments of progressively smaller size
(Fig. 4c). Thus, the enzyme favours nicking of supercoiled DNA,
with more extensive DNA degradation seen only under extended
incubation. To measure the rates of supercoiled plasmid nicking
under pseudo-single turnover conditions, 200 nM protein was
incubated with 2 nM plasmid, and the fraction of supercoiled
plasmid cleaved was quantified, normalised, plotted and fitted to
an exponential equation as described in the Methods. Two
biological replicates and six technical replicates were carried out,
yielding a rate of 0.81 ± 0.15 min−1 (Fig. 4d).
Can1 cleaves supercoiled DNA at random sites. To determine
whether Can1 nicks supercoiled DNA at a specific site, we
compared its activity to the Nickase Nt.BspQI, which nicks DNA
specifically at 5’-GCTCTTCN/ sites, and has one recognition site
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Fig. 4 Can1 nicks supercoiled plasmid when activated by cA4 in the presence of MnCl2. a The nuclease domain of Can1 (orange) in complex with the
modelled position of dsDNA (based on homologous structures, the nuclease domains of AgeI (PDB: 5DWB) and NgoMIV (PDB: 1FIU)). The nuclease-like
domain of Can1 is shown in cyan and Arg206 and Arg249 are shown as sticks. b Native agarose gel analysis of plasmid (2 nM) cleavage by Can1 (200
nM), showing rapid nicking in the presence of cA4 (200 nM) and MnCl2 (5 mM) (lanes 8-11). Standards corresponding to supercoiled, linear and partially
nicked plasmid are shown in lanes 2-4. Lanes 5-7 show the reactions incubated for 5 min without protein (c1), MnCl2 (c2) or cA4 (c3), respectively. Can1
variants E541A/D543A, K90E and R206E/R249E generate minimal nicked product after 5 min (lanes 12-14). M—DNA size markers. c Extended time
course of plasmid degradation by Can1. Rapid nicking is followed by slower degradation to small linear products over 2 h. Standards are as described in part
b. d Single-turnover kinetic analysis of supercoiled plasmid nicking by Can1, under the conditions in b, yield a rate constant of 0.81 ± 0.15 min−1. Data points
are the mean of triplicate experiments with the standard deviation shown. Source data are provided as a ‘Source Data’ file.
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in the plasmid pEV5HisTEV. By using alkaline agarose gel elec-
trophoresis to analyse the cleavage products, we ensured that
DNA migrated in single stranded form. Nt.BspQI nicking gen-
erated a single product band of 5.4 kb, as expected (Fig. 5a), whilst
cleavage by Nt.BspQI followed by BamHI (which also has a single
recognition site in pEV5HisTEV) yielded 3 bands—a 5.4 kb band
representing the strand that is cut only by BamHI, and two
smaller bands of 3.0 and 2.4 kb that result from cleavage of the
Nt.BspQI nicked strand by BamHI, as shown in the schematic.
Can1 also generated a nicked strand of 5.4 kb, but when this
product was further digested by BamHI a smear of smaller DNA
products were observed rather than specific fragments (Fig. 5a).
This demonstrates that Can1 nicks supercoiled DNA at random
sites.
Nucleases within the superfamily which contains the PD-D/
ExK motif typically catalyse phosphodiester bond cleavage by a
two metal ion catalytic mechanism26. A water molecule is
deprotonated by one metal ion and used as a nucleophile to
attack the scissile phosphate bond, generating 5’-phosphate and
3’-hydroxyl products26. To determine whether Can1 conformed
to this mechanism, we incubated the nicked plasmid generated by
Can1 with DNA ligase, followed by DNA gyrase, as described in
the Methods. Commercial nicking endonuclease Nt.BspQI was
used as a positive control. After incubating nicked plasmid with
ligase, various relaxed topoisomers were observed (Fig. 5b),
suggesting that the nicked plasmid was ligated to covalently-
closed circular plasmid. The products were further incubated with
DNA gyrase to introduce negative supercoils (Fig. 5b), confirming
that ligation of the nicked sites had occurred. Thus, Can1
hydrolyses phosphodiester bonds in supercoiled DNA substrates,
generating ligatable 5’-phosphate and 3’-hydroxyl products.
Structural rearrangements upon cA4 binding. The binding of a
ligand as large as cA4 will inevitably require structural rearran-
gements of Can1, particularly as it is completely buried in the
complex. As we lacked a crystal structure of apo Can1, we
investigated the solution state of apo Can1 and Can1 bound to
cA4 using small angle X-ray scattering (SAXS). Size exclusion
chromatography coupled SAXS was performed on apo Can1 to
ensure optimal background subtraction and sample character-
isation, and a single, well defined elution peak was observed. The
SAXS derived radius-of-gyration, Rg, shows the apo state is less
compact than Can1 in complex with cA4, as characterised by a
larger Rg (28.44 ± 0.13 Å vs 30.13 ± 0.15 Å), particle volume and
maximum dimension, dmax. The dimensionless Kratky plot
(Fig. 6a) suggests Can1 is not globular in either the bound or apo
state, which is consistent with the observations of the X-ray
crystal structure of Can1 bound to cA4. Furthermore, analysis of
the real-space pairwise distances within the particles, P(r)-dis-
tribution, shows the apo state of Can1 has a wider overall dis-
tribution (Fig. 6b) with a substantially larger maximum
dimension, dmax (121.5 Å vs 101.5 Å for the complex), suggesting
there is a significant conformational difference between the
bound and apo states in solution. In fact, fitting the Can1 crystal
structure to the SAXS data results in a Chi2 > 80.
To investigate the structural changes required to explain the
SAXS dataset of the apo state, we performed a distance restrained,
rigid body molecular dynamics simulation that restricted the
search to the distances within the apo state P(r)-distribution. The
Can1 crystal structure demonstrated clearly defined domains that
were used to define rigid bodies to which centre-of-mass
restraints were assigned. Given the observed conservation of the
CARF dimer conformation in the cA4 bound Can1 and apo
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Fig. 5 Can1 nicks plasmid DNA at random sites, leaving ligatable DNA ends. a Plasmid nicking by the Nickase Nt.BspQI and Can1 were analysed by
alkaline agarose gel electrophoresis where all DNA is denatured into single-stranded products. Both generate linear 5.5 kb products. When Nt.BspQI nicking
at its recognition site is followed by BamHI digestion, the expected linear products of 3.0 and 2.5 kb are also observed. Can1, which nicks at random sites,
generates a wide range of linear products following BamHI digestion that appear as a smear in the gel. b Both the Nickase Nt.BspQI and Can1 nick
supercoiled plasmid to yield open circle DNA that can be visualised following agarose gel electrophoresis. Ligation of these products by DNA ligase
generates closed circular DNA with a range of topoisomers. Addition of DNA gyrase restores the supercoiled DNA substrate. Control lanes are as for
Fig. 4. Source data are provided as a ‘Source Data’ file.
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VC1899 structures, we treated this unit as a rigid body. We
generated ~2500 conformations that were subsequently fit to the
apo state SAXS data. A best single-state model was found (best χ2
1.81; Fig. 6c, d), where there is movement of the nuclease and
nuclease-like domains away from the core CARF dimer. This has
the effect of exposing the cA4 binding pocket to solvent, which is
required for binding. Analysis of the temperature factor of
residues in Can1 (Fig. 6e) shows the nuclease domain residues
have higher average temperature factors than the other domains
in Can1, which supports the hypothesis that the nuclease domain
is more mobile. We envisage Can1 in solution is sampling
between the open and closed states, exposing the cA4 binding site
in the CARF dimer. Upon cA4 binding, the closed conformation
of the protein is stabilised, as observed in the crystal structure. A
potential ‘hinge’ between the second CARF domain and the
nuclease domain to allow these open and closed states is the
connecting loop which contains a Gly423/Arg424/Pro425 motif.
The loop between the first CARF domain and the nuclease-like
domain is longer, and contains two ‘PPG’motifs (Pro160/Pro161/
Gly162 and Pro165/Pro166/Gly167) which are likely to be
important in providing flexibility between the domains. A
superimposition of Can1 onto VC1899, structurally aligned on
the CARF domain dimer from each protein only, suggests the
possibility of movement of the nuclease and nuclease-like
domains between the open and closed states (Supplementary
Fig. 10). It is possible that a complex population of open and
closed structures exists in the absence of cA4.
Discussion
The structure of the Can1 enzyme clearly demonstrates that the
two halves of the protein, comprising a CARF domain N-terminal
to a nuclease fold domain, are related to one another. Coupled to
the observation that each half is clearly related to the DUF1887
family, as exemplified by the VC1889 protein, we can postulate a
scenario whereby gene duplication, fusion and subsequent
divergent evolution of an ancestral DUF1887 family member gave
rise to the Can1 family. Can1 appears to be limited to members of
the genus Thermus, but in contrast DUF1887 is much more
widely distributed, with representatives found throughout the
bacterial phyla and is particularly common in the proteobacteria.
Although no member of the DUF1887 family has yet been
characterised biochemically, given the relationship with Can1 and
the conservation of a nuclease active site we suggest the provi-
sional name “Can2” (CRISPR ancillary nuclease 2) for this family.
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Fig. 6 Structural rearrangements of Can1 upon cA4 binding in solution. a Dimensionless Kratky plot of Can1 in the presence (blue) and absence (black) of
cA4. Data were normalised with Rg and I(0) of 28.88 ± 0.13 Å and 1.090E-1 ± 1E-4 respectively for Can1 with cA4 and 30.26 ± 0.11 Å and 8.99E-2 ± 6.5E-05
respectively for apo Can1. Cross-hairs mark the Guinier-Krakty point or peak position for an ideal, globular particle. b Paired-distance, P(r), -distribution
function performed as an indirect Fourier transform using the Moore method. P(r)-distributions were normalised to particle’s Porod volume using 121,421
Å3 and 132,291 Å3 for the Can1 with cA4 (blue) and apo Can1 (black), respectively. Widening of the distribution for apo Can1 suggests larger distances are
more accessible. c Fit of apo Can1 SAXS data (black circles) using atomistic model from constrained torsion angle molecular dynamics. Best single-state
model (red line), χ2 1.8, identifies a model that opens through translation of the nuclease domain. The best open model was achieved where the CARF
dimer was maintained as a rigid body and the nuclease-like domain was allowed to vary ± 5 Å from its observed position. The nuclease domain was treated
as a separate, rigid body tethered by an unconstrained loop (residues 423 to 428). Residuals of the fit are presented. The inset shows the fit of the Can1
crystal structure (cyan) to apo-state SAXS data (black). d Surface representation of Can1 as predicted by SAXS in the absence of cA4 (left) (cA4 is shown
to illustrate the binding position and demonstrates the CARF domains are immobile) and the structure of Can1 in complex with cA4 solved by X-ray
crystallography (right). Coloured as first CARF domain (magenta), nuclease-like domain (cyan), second CARF domain (green), nuclease domain (orange).
Loops between the domains are not shown for clarity. A molecule of cA4 bound to Can1 is shown in yellow spheres. e The crystal structure of Can1 shown
in cartoon form coloured by temperature factor from white (high temperature factor) to dark purple (low temperature factor). A molecule of cA4 bound to
Can1 is shown in yellow spheres.
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Analysis of the structure of a CARF domain protein bound to
its cognate cyclic oligoadenylate ligand can be used to draw some
general conclusions about the mechanism of recognition. Can1 is
unusual in being a monomeric protein with two non-identical
CARF domains, and therefore possesses less intrinsic symmetry
than most family members. cA4 is bound in a markedly asym-
metrical conformation, which is in part exaggerated by the
position of one adenine base in an axial position, driven by a
stacking interaction with a tryptophan residue. Many different
residues, the vast majority from the two CARF domains, con-
tribute to the ligand binding pocket, which appears to be largely
pre-formed in the apo protein. A significant number of these
interactions are with protein main chain atoms, and although
some of these are structurally conserved between the two ‘halves’
of Can1, the difference in side chain residue meant they would
not have been predicted by sequence alone. Site-directed muta-
genesis has highlighted a key role of Lys90, which occupies a
central position in CARF domain 1 at the N-terminus of an α-
helix, by forming a salt bridge with a bridging phosphate of cA4;
basic residues at an equivalent position have been shown to be
essential for cA4 recognition in other CARF family proteins10,12.
Recently, the structures of two CARF-HEPN family ribonu-
cleases, Csm6 from Thermococcus onnurineus and Csx1 from S.
islandicus, have been solved with cA4 bound31,32. Although each
of these proteins have the basic unit of a CARF domain for cA4
binding in common with Can1, there is little sequence con-
servation across the three proteins. In particular, Can1 lacks
conserved Y14, Y19, S51, H155, and N158 cA4-interacting resi-
dues identified as conserved across the Csx1/Csm6 family32.
N158 is replaced by K90 in Can1, reflecting the importance of this
position in the centre of the CARF domain for cA4 binding
despite a lack of sequence conservation. Residues W14 and H132,
identified as important for cA4 cleavage by Csm631, are also not
conserved in Can1, and we see no evidence for ring nuclease
activity by Can1 in vitro. The three enzymes bind cA4 in different
orientations, emphasising the conformational flexibility possible
for this large cyclic nucleotide.
The cA4 ligand is completely buried in the Can1 complex,
demonstrating that significant protein conformational changes
are required to facilitate binding. The close structural agreement
observed for the two CARF domains of Can1 compared to the
VC1899 apo protein suggests that the CARF dimer conformation
does not change radically upon cA4 binding. In contrast, the
temperature factors of the residues in the crystal structure, cou-
pled with SAXS analysis, suggest that the nuclease domain is
mobile, which would help facilitate cA4 binding to apo Can1.
Modelling of dsDNA binding by the nuclease domain, coupled
with the observation that conserved basic residues in the
nuclease-like domain are essential for activity (presumably due to
a role in DNA binding rather than directly in catalysis), suggests
that cA4 binding allows the nuclease and nuclease-like domains to
assemble into a functional dsDNA binding site, activating the
enzyme. Modelling of dsDNA from homologous structures sug-
gests a further modest closure of the cleft between the two
domains may occur upon DNA binding, although this will
depend on the precise position of the dsDNA substrate bound
to Can1.
An emerging theme of CRISPR-based defence systems is the
role of collateral (non-specific) nucleic acid degradation in
immunity (reviewed in ref. 33). In addition to the cOA activated,
non-specific ribonucleases described above for type III systems,
type VI (Cas13) effectors provide effective immunity against
mobile genetic elements by degrading RNA non-specifically34,35.
The mechanism for this immunity was recently shown to result in
degradation of host, rather than virus, RNA, driving infected cells
into dormancy and thus preventing the spread of infection36.
DNA is also a target for collateral degradation. Type III effectors
hydrolyse ssDNA on binding target RNA—an activity that
appears largely non-specific in vitro37–39, but which may favour
transcribing phage DNA in vivo40. Likewise, type V effectors such
as Cas12a possess a non-specific ssDNA degradation activity that
is licensed by crRNA-dependent DNA binding41,42.
Here, we have described another option available to CRISPR
defence systems: cyclic oligoadenylate-dependent supercoiled
DNA cleavage by the Can1 enzyme. Once activated by cA4
generated in response to detection of foreign RNA, Can1 cleaves
supercoiled DNA to generate nicked products. In vivo, such an
activity is likely to slow down the replication kinetics of rapidly-
replicating phage, where nicks can result in the collapse of DNA
replication forks to generate double-strand breaks. In contrast,
such nicks are not too great a burden for the slowly-replicating
host chromosome as they are easily repaired by DNA ligase. This
nickase activity will operate in parallel with non-specific RNA
degradation by the T. thermophilus Csm6 enzymes (Fig. 7),
providing layered defence against mobile genetic elements
detected by the CRISPR system. Given the structural conservation
of CARF and nuclease domains in the Can2 (DUF1887) family,
we predict that this family, which is widespread in bacteria,
functions in a similar way to Can1 by cleaving supercoiled DNA.
However, there is a key difference—the Can2 homodimer has two
nuclease active sites, which may have functional consequences. In
conclusion, we have revealed key molecular details of the cOA-
mediated anti-viral defence mediated by type III CRISPR systems
—one of the most common types of CRISPR effectors found in
nature.
Methods
Expression and purification of Can1 and variants. Two overlapping gBlock
fragments to form the synthetic can1 gene were purchased from Integrated DNA
Technologies, Coralville, IA, United States (IDT) and cloned into the pEV5HisTEV
vector using NcoI and HindIII restriction enzyme sites25. The cloning strategy
resulted in the addition of two residues (Leu and Glu) to the C-terminus of the
protein. The full sequence of the synthetic gene is shown in Supplementary Table 1.
The variants E541A/D543A, K90E, N12A, W42A, H113A, Q222E, and R206E/
R249E were generated using the QuikChange Site-Directed Mutagenesis kit as per
manufacturer’s instructions (Agilent Technologies). Primer sequences for muta-
genesis are shown in Supplementary Table 2. The pEV5HisTEV-can1 wild-type
and variant constructs were transformed into C43 (DE3) E. coli cells (Sigma
Aldrich). Protein expression was induced with 0.4 mM isopropyl-β-D-1-thioga-
lactoside (IPTG) at an OD600 of ~0.6 and grown overnight at 25 °C. Cells were
harvested and resuspended in lysis buffer containing 50 mM Tris–HCl pH 7.5, 500
mM NaCl, 10 mM imidazole and 10% glycerol, and lysed by sonicating six times
for 2 min on ice with 2 min rest intervals. Can1 was purified with a 5 ml HisTrapFF
column (GE Healthcare), washed with 5 column volumes (CV) of buffer containing
50 mM Tris–HCl pH 7.5, 500 mM NaCl, 30 mM imidazole and 10% glycerol, and
eluted with a linear gradient of buffer containing 50 mM Tris–HCl pH 7.5, 500 mM
NaCl, 500 mM imidazole and 10% glycerol across 15 CV. Protein containing
fractions were concentrated and the hexa-histidine affinity tag was removed by
incubating protein with Tobacco Etch Virus (TEV) protease (10:1) overnight at
room temperature.
Cleaved Can1 was isolated from the TEV protease by repeating the immobilised
metal affinity chromatography step and collecting the unbound fraction. Size
exclusion chromatography was used to further purify Can1, eluting protein
isocratically with buffer containing 20 mM Tris-HCl pH 7.5, 150 mM NaCl. The
protein was concentrated using a centrifugal concentrator, aliquoted and frozen at
−80 °C. For seleno-methionine labelling, the pEV5HisTEV-Can1 construct was
transformed into B834 (DE3) E. coli (Novagen) and cultures grown in M9 minimal
medium supplemented with Selenomethionine Nutrient Mix (Molecular
Dimensions, Newmarket, Suffolk, UK) and 50 mg L−1 (L)-selenomethionine
(Acros Organics). Protein was purified as described above.
Can1 nuclease assay. In total 200 nM Can1 was incubated with 2 nM plasmid
pEV5HisTEV for the time indicated at 60 °C in 20 μl final reaction volume in
20 mM MES pH 6.5, 100 mM NaCl and 1 mM EDTA supplemented with 5 mM
MnCl2 and 200 nM cA4. Reactions were stopped by addition of 10 mM EDTA.
Control reactions were carried out by incubating plasmid without protein, MnCl2
or cA4 under the same conditions. For kinetic analysis, triplicate experiments were
carried out by incubating Can1 in 140 μl final reaction volume under the condi-
tions described above. 20 μl was removed and quenched by addition of 2 μl
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100 mM EDTA at desired time points. To differentiate nuclease activity of wild
type Can1 and all variants, the kinetic assay was changed by reducing protein and
cA4 concentration to 100 nM and 20 nM, respectively. After adding 4 μl 6× DNA
loading dye (New England BioLabs, Ipswich, MA, United States), 10 μl sample was
analysed by 0.7% native agarose gel electrophoresis. Gels were scanned by Typhoon
FLA 7000 imager (GE Healthcare) at a wavelength of 532 nm, quantified using the
Bio-Formats plugin43 of ImageJ as distributed in the Fiji package44 and plotted
against the time using Kaleidagraph (Synergy Software, Reading, PA, United
States). The data were fitted to a single exponential curve1.
Nicking endonuclease digestion. Nicking endonuclease Nt.BspQI (New England
BioLabs, Ipswich, MA, United States) hydrolyses the phosphodiester bond between
the 3’-hydroxyl and 5’-phosphate on one strand of dsDNA. Therefore, the open
circle conformation of pEV5HisTEV containing the unique GCTCTTCN^ site was
generated by Nt.BspQI. All incubations with commercial enzymes followed man-
ufacturer’s instructions.
Alkaline agarose gel electrophoresis. DNA products were separated on 0.7%
alkaline agarose gels (30 mM NaCl, 2 mM EDTA and 0.7% agarose). The gels were
immersed for 2 h in alkaline electrophoresis buffer (30 mM NaOH, 2 mM EDTA)
before running. Samples and ladder were denatured with 6× alkaline electro-
phoresis loading dye (180 mM NaOH, 6 mM EDTA, 18% Ficoll 400 and 0.05%
bromophenol blue) and heated at 95 °C for 5 min, and then chilled on ice. Gels
were run at 2 V cm−1 for 10 h in alkaline electrophoresis buffer, then soaked in
renaturing buffer (500 mM Tris–HCl pH 8.0) for 30 min and stained with SYBR
Gold (Thermo Scientific, Waltham, MA, United States) for 30 min. Gels were
destained with H2O and scanned by Typhoon FLA 7000 imager at a wavelength of
532 nm.
Plasmid ligation and supercoiling. In total 200 nM Can1 was incubated with
2 nM plasmid pEV5HisTEV in 20 μl final reaction volume as described above.
Reactions were quenched and deproteinized by PCR Clean-Up System (Promega,
Madison, Wisconsin, United States). In total 10 μl eluted product was incubated
with T4 DNA Ligase (New England BioLabs, Ipswich, MA, United States) in ligase
buffer (50 mM Tris–HCl pH 7.5, 10 mM MgCl2, 1 mM ATP and 10 mM DTT) in
20 μl final reaction volume following manufacturer’s instructions. After inactivat-
ing at 65 °C for 10 min, ligated products were incubated with E. coli DNA gyrase
(Inspiralis, Norwich, UK) in gyrase buffer (35 mM Tris–HCl pH 7.5, 24 mM KCl,
4 mM MgCl2, 2 mM DTT, 1.8 mM spermidine, 1 mM ATP, 6.5% glycerol and
0.1 mgmL−1 albumin) in 40 μl final reaction volume as per manufacturer’s
instructions. Reactions were deproteinized by phenol chloroform extraction before
analysis by agarose electrophoresis.
Preparation of cA4. cA4 was purchased from Biolog Life Science Institute, Bre-
men, Germany. 32P labelled cA4 was prepared by incubating 120 µg S. solfataricus
Csm complex with 0.5 mM ATP, 1 mM MgCl2 and 100 nM target RNA in 20 mM
MES pH 5.5, 100 mM K-glutamate and 1 mM DTT for 2 h at 70 °C. The reaction
product was isolated by phenol-chloroform extraction, followed by chloroform
extraction, and frozen at −20 °C25.
Can1 and cA4 electrophoretic mobility shift assay. In total 100 nM 32P labelled
cA4 was incubated with different concentrations of Can1 for 10 min at room
temperature in 10 μl final reaction volume in 20 mM MES pH 6.5, 100 mM NaCl,
1 mM EDTA, 5 mMMnCl2 and 2 μM BSA. In total 10 μl of 20% glycerol was added
to each reaction before loading onto native acrylamide gel (15% acrylamide, 1 ×
TBE). 32P labelled cA4 was visualised by phosphorimaging using a Typhoon FLA
7000 imager (GE Healthcare). All images were analysed by Bio-Formats plugin43 of
ImageJ as distributed in the Fiji package44.
Crystallisation of Can1. Selenomethionine labelled Can1 at 10.4 mg mL−1 was
mixed in a 1:2 molar ratio with cA4 and incubated at room temperature for 30 min,
before centrifugation at 13,000 rpm prior to crystallisation. Sitting drop vapour
diffusion experiments were set up at the nanoliter scale using both commercially
available and in-house crystallisation screens, and subsequently incubated at 293 K.
Crystals appeared in many conditions, but those used for data collection grew from
a reservoir solution of 20% PEG 3350, 200 mM sodium citrate, and 100 mM bis-
Tris propane, pH 6.5. Crystals were harvested and transferred to a drop of reservoir
solution with the addition of 20% glycerol before cryo-cooling. Attempts to crys-
tallise Can1 in the absence of cA4 did not yield crystals.
X-ray data processing, structure solution, and refinement. X-ray data were
collected at a wavelength of 0.9159 Å, on beamline I04-1 at Diamond Light Source,
at 100 K to 1.83 Å resolution. Data were automatically processed using Xia245 using
XDS and XSCALE46. A strong anomalous signal was detected to 2.36 Å resolution.
The data were phased using AutoSol in Phenix and the initial model was built in
AutoBuild47. Model refinement was achieved by iterative cycles of REFMAC548 in
the CCP4 suite49 and manual manipulation in COOT50. Electron density for cA4
was clearly visible in the maximum likelihood/σA weighted Fobs—Fcalc electron
density map at 3σ. The coordinates for cA4 were generated in ChemDraw (Perkin
Elmer) and the library was generated using acedrg27, before fitting of the molecule
in COOT. Model quality was monitored throughout using Molprobity51 (score
1.05; centile 100). Ramachandran statistics are 98.5% favoured, 0% disallowed.
Data and refinement statistics are shown in Supplementary Table 3. The coordi-
nates and data have been deposited in the Protein Data Bank with deposition
code 6SCE.
Small angle X-ray scattering. The apo-state of Can1 was measured using size
exclusion chromatography coupled to small angle X-ray (SEC-SAXS) on beamline
B21 at Diamond Light Source. A 4.8 ml Shodex KW-402.5 column was pre-
equilibrated with 3 column volumes of buffer containing 20 mM Tris pH 7.5 and
150 mM NaCl. SEC-SAXS experiments were measured at a flow rate of 0.160 ml
per minute with 2 s exposure per frame in a 1.5 mm diameter, 10 μm thick quartz
capillary flow cell and a 800 μm squared X-ray beam focused on an Eiger 4M
detector 4 m from the sample. Column performance and instrumentation
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Fig. 7 Cartoon of the type III-A CRISPR defence system of T. thermophilus. The type III-A effector binds phage RNA, activating the cyclase domain which
synthesises cA4 from ATP. cA4 binds to and activates the two Csm6 family RNases (encoded by tthb144 and tthb152) and the DNA nickase Can1 (encoded
by tthb155), providing a multi-layered defence against mobile genetic elements.
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calibration was checked by measuring a 45 μl sample of BSA injected at 10 mgmL
−1. In total 45 μl of the apo-state of Can1 was injected (10.4 mg mL−1, 140 μM) and
frames were collected for a total of 30 min. The flat radius-of-gyration, Rg, and
nearly ideal overlay of the frames constituting the merged frames suggests the
measured frames are free of interparticle interference (Supplementary Data 1).
To measure Can1 in the presence of cA4, a SEC purification of Can1 was
performed at the beamline by manually collecting the peak fraction (~100 μl)
during an additional SEC run of the same 10.4 mgmL−1 protein stock. The peak
fraction represented a dilution of ~3.2× for a final concentration of 44 μM of
purified protein. A corresponding buffer blank (~1 ml) was collected before sample
injection. Samples were mixed with ligand to a final concentration of 0.25 mM and
3 dilutions of the sample were made first by making a two-thirds dilution of the
master stock followed by two consecutive nine-tenths dilutions. Dilutions were
performed with the buffer blank supplemented with ligand to maintain a ratio of 3-
to-1 ligand-to-protein ratio. Samples were processed in batching mode at 25 μl per
sample using the Arinax sample handling robot.
Raw SAXS images were processed with the DAWN52 processing pipeline at the
beamline to produce normalised, integrated 1-D un-subtracted SAXS curves. SEC-
SAXS analysis and buffer subtractions were performed with the program ScÅtter
(www.bioisis.net). Modelling of the apo-state was performed using the program
CNS version 1.3 (cns-online.org/v1.3)53. First, missing loops and tails from the X-
ray crystal structure were added by building an extended chain model of Can1 with
generate_extended.inp. Protein only distance restraints were extracted from the
ligand bound crystal structure of Can1 and used as pseudo-NOE constraints to fold
the extended chain into the known parts of the crystal structure (model_anneal.
inp). The resulting structure matched the crystal structure with missing loops and
tails added back but in unconstrained positions. The folded structure (ground-
state) was used as a starting conformation for limited rounds of simulated
annealing or constant temperature simulations (anneal.inp) to sample various
conformations as domain-to-domain distance restraints were varied. Specifically,
the two CARF domains were kept as a rigid unit, whereas either the nuclease or
nuclease-like domains were allowed to vary from their ground-state positions as
rigid bodies. An initial simulation allowed the non-CARF domains to move as
unconstrained rigid bodies only tethered by the linking peptide regions. Additional
simulations were performed that constrained the non-CARF domains within 5 and
10 Å of their observed crystallographic positions. These were loose restraints added
between the centre-of-masses for each domain based on the P(r)-distribution of the
apo-state SAXS data. Specifically, no distances were allowed to exceed dmax and
distances were given upper and lower limits determined as π/qmax. A total of 2430
conformations were generated and used as an ensemble fit with the online web-app
multi-FOXS54 which identified the best two-state model for the apo-state. Single
model fits were performed with FOXS (http://modbase.compbio.ucsf.edu/foxs)55.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The final protein model and structure factors presented in this study have been deposited
in the Protein DataBank with the accession code 6SCE. The SAXS data has been
deposited in bioisis with the accession codes CAN1AP and CAN1C4. The source data
underlying Figs. 4b–d, 5a, b and Supplementary Fig. 5a, b are provided as a Source Data
file. Other data presented in this study are available from the corresponding authors
upon reasonable request.
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